Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-Center, Randomized, Controlled, Double-Blind, Split-Face Study of the Safety and Effectiveness of ELLANSÉ®-S Dermal Filler in the Treatment of Nasolabial Folds

NCT06984835 is registered in ClinicalTrials.gov with AQTIS Medical B.V. as lead sponsor.

NCT NCT06984835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06984835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-Center, Randomized, Controlled, Double-Blind, Split-Face Study of the Safety and Effectiveness of ELLANSÉ®-S Dermal Filler in the Treatment of Nasolabial Folds
Lead sponsor
AQTIS Medical B.V.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 31, 2025
Completion date
December 31, 2027
Enrollment
126 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

nasolabial folds